Gene | Genotype | RA patients, no. (%) |
Controls, no. (%) |
Alleles associated with susceptibility (P-value) |
-590 (IL-4) and -137 (IL-18) |
СС GG ТТ GG СТ GG СС GC ТТ GC СТ GC СС CC ТТ CC СТ CC |
9 (13%) 3 (4%) 14 (20%) 11 (16%) 1 (1%) 31 (45%) 000 |
46 (35%) 1 (1%) 23 (17%) 31 (23%) 3 (2%) 18 (14%) 4 (3%) 0 7 (5%) |
590T and 137C (0.01955) |
-819 (IL-10) and -592 (IL-10) |
CC CC ТТ CA CT CA CC CA CC AA TT CC TT AA CT AA CT CC |
28 (41%) 0 24 (35%) 9 (13%) 00 8 (11%) 00 |
84 (63%) 0 43 (32%) 1 (1%) 00 5 (4%) 00 |
819C and 592A (0.00754) |
-238 (TNFα) and -590 (IL-4) |
GG CC GA CC GG CT GA CT GG TT GA TT |
17 (25%) 3 (4%) 42 (61%) 3 (4%) 4 (6%) 0 |
79 (59%) 2 (1%) 46 (34%) 2 (1%) 4 (3%) 0 |
238A and 590T (0.0311) |
-308 (TNFα) and -590 (IL-4) |
GG CC GA CC GG CT GA CT GG TT GA TT |
12 (17%) 8 (12%) 23 (33%) 22 (32%) 2 (3%) 2 (3%) |
61 (45%) 20 (15%) 36 (27%) 12 (9%) 2 (2%) 2 (2%) |
308A and 590T (0.0361) |
-308 (TNFα) and -592 (IL-10) |
GG CC GA CC GG CA GA CA GA CA GA AA |
19 (27%) 9 (13%) 14 (20%) 19 (27%) 4 (6%) 4 (6%) |
56 (42%) 28 (21%) 38 (29%) 6 (4%) 5 (4%) 0 |
308A and 592A (0.00471) |
-308 (TNFα) and -137 (IL-18) |
GG GC GA GC GG GG GA GG GG CC GA CC |
20 (29%) 23 (33%) 17 (25%) 9 (13%) 00 |
42 (32%) 10 (7%) 51 (38%) 19 (14%) 6 (5%) 5 (4%) |
308A and 137C (0.0294) |
Table 4: Presence of combined genotypes among patients with RA and healthy individuals and their significant association with RA (p<0.05). |